- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04513080
Message-Based Psychotherapy and Digital Treatment Sequences for Depression
Study Overview
Status
Conditions
Intervention / Treatment
- Behavioral: Message-Based Psychotherapy (MBP)
- Behavioral: Video-Chat Psychotherapy (VCP)
- Behavioral: Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy
- Behavioral: Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy
- Behavioral: High Monetary Incentive (HMI)
- Behavioral: Low Monetary and Alternative Incentive (LMAI)
Detailed Description
This is a fast track Small Business Innovation Research (SBIR) proposal that will (1) test the effectiveness of daily, message-based psychotherapy (MBP) for depression, compared to traditionally delivered, video-chat psychotherapy (VCP) and (2) develop an evidence-based treatment sequence for those who do not respond to either daily MBP or VCP.
Phase 1 consists of a pilot study to determine the best incentive model to retain a sample of people 18 years old and older with depression into a SMART trial. Information from this pilot will inform the retention strategy for Phase 2.
Phase 2 is a 12-week, randomized clinical trial using a SMART design to test the following aims: 1. Determine the relative effectiveness of daily MBP compared to weekly VCP in treating symptoms of depression and improving social functioning; 2. For those who fail to respond to 6 weeks of weekly VCP only, determine whether the addition of daily messaging, or a switch to monthly video-chat plus daily messaging improves depression and functional outcomes; and 3. For those who fail to respond to 6 weeks of daily MBP, whether the addition of monthly video-chat or weekly video-chat improves outcomes. Participants will provide data on mood, activity, and functioning, and we will collect data on use of treatment (texts and sessions), and working alliance.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10025
- Talkspace
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion and exclusion criteria are the same for Phase 1 and Phase 2.
Inclusion Criteria:
- 18 years old or older
- English or Spanish speaking
- Live in the United States
- Score of 10 or greater on the Patient Health Questionnaire-9 (PHQ-9) screening
- Receive a diagnosis of depression from a Talkspace intake clinician
Exclusion Criteria:
- Under the age of 18
- Non-English or Spanish speaking
- Do not meet criteria for a depressive disorder
- Participants with active suicidal ideation or with a primary diagnosis of psychosis will also be excluded and referred to intensive care.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Phase 2: Message-Based Psychotherapy (MBP; Level 1 and Level 2)
Phase 2 participants who respond to Message-Based Psychotherapy (MBP; Level 1) by 5 weeks of care will continue in this condition from weeks 6 to 12 (MBP; Level 2).
|
Message-Based Psychotherapy (MBP) allows patients to chat with an assigned licensed therapist as frequently as they wish.
After consumers complete an intake and select a therapist, the consumer can begin chatting with their therapist right away, and as often as they wish.
Therapists respond to text within 15 minutes to an hour during office hours, and within 14 hours outside of office hours.
Thus, MBP is not fully synchronous.
This enables therapists to deliver care to a larger number of patients than is possible under synchronous methods by disentangling the therapist's time from the patient's time to respond.
It also has the potential to improve quality as it gives the therapist time to think through the most effective response and intervention.
MBP will be based on CBT, PST or IPT intervention strategies.
|
|
Experimental: Phase 2: Video-Chat Psychotherapy (VCP; Level 1 and Level 2)
Phase 2 participants who respond to Video-Chat Psychotherapy (VCP; Level 1) by 5 weeks of care will continue in this condition from weeks 6 to 12 (VCP; Level 2).
VCP consists of weekly psychotherapy appointments that last between 30-45 minutes.
|
Video-Chat Psychotherapy (VCP) consists of weekly psychotherapy appointments that last between 30-45 minutes.
These sessions are conducted using Agora, a secure, HIPAA-compliant video conferencing service that is seamlessly integrated into the Talkspace platform application.
Therapists will provide evidence-based treatments for depression and anxiety.
|
|
Experimental: Phase 2: MBP (Level 1) to Premium Plan (MBP with monthly VCP; Level 2)
Phase 2: This arm includes participants in MBP (Level 1) who do not respond to treatment by week 5.
The Premium Plan intervention consists of MBP with monthly VCP (Level 2).
The Premium Plan allows patients unlimited MBP and once a month, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two Level 2 conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) allows patients to chat with an assigned licensed therapist as frequently as they wish.
After consumers complete an intake and select a therapist, the consumer can begin chatting with their therapist right away, and as often as they wish.
Therapists respond to text within 15 minutes to an hour during office hours, and within 14 hours outside of office hours.
Thus, MBP is not fully synchronous.
This enables therapists to deliver care to a larger number of patients than is possible under synchronous methods by disentangling the therapist's time from the patient's time to respond.
It also has the potential to improve quality as it gives the therapist time to think through the most effective response and intervention.
MBP will be based on CBT, PST or IPT intervention strategies.
Message-Based Psychotherapy (MBP) with monthly Video-Chat Psychotherapy (VCP) allows patients unlimited texting with their therapist and once a month, 30-45 minute video chat with the same therapist.
Therapist and participants schedule their video chat appointment to occur at once a month interval during therapist office hours.
The content of these sessions, as well as the MBP portion of care, will be based on CBT, PST or IPT.
In Phase 1, this is referred to as "Switch Arm" (for participants assigned to VCP at baseline) or "Minimal Augmentation" (for participants assigned to MBP at baseline).
In Phase 2, this is referred to as the "Premium Plan".
|
|
Experimental: Phase 2: MBP (Level 1) to Ultimate Plan (MBP with weekly VCP; Level 2)
Phase 2: This arm includes participants in MBP (Level 1) who do not respond to treatment by week 5.
The Ultimate Plan intervention consists of MBP with weekly VCP (Level 2).
The Ultimate Plan allows patients unlimited MBP and weekly, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two Level 2 conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) allows patients to chat with an assigned licensed therapist as frequently as they wish.
After consumers complete an intake and select a therapist, the consumer can begin chatting with their therapist right away, and as often as they wish.
Therapists respond to text within 15 minutes to an hour during office hours, and within 14 hours outside of office hours.
Thus, MBP is not fully synchronous.
This enables therapists to deliver care to a larger number of patients than is possible under synchronous methods by disentangling the therapist's time from the patient's time to respond.
It also has the potential to improve quality as it gives the therapist time to think through the most effective response and intervention.
MBP will be based on CBT, PST or IPT intervention strategies.
Message-Based Psychotherapy (MBP) with weekly Video-Chat Psychotherapy (VCP) allows patients access to both unlimited MBP, but will be able to schedule weekly, 30-45 minute video chat with the same therapist.
Therapists will provide care based on CBT, PST or IPT.
In Phase 1, this is referred to as the "Augmentation Arm".
In Phase 2, this is referred to as the "Ultimate Plan."
|
|
Experimental: Phase 2: VCP (Level 1) to Premium Plan (MBP with monthly VCP; Level 2)
Phase 2: This arm includes participants in VCP (Level 1) who do not respond to treatment by week 5.
The Premium Plan intervention consists of MBP with monthly VCP (Level 2).
The Premium Plan allows patients unlimited MBP and once a month, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two Level 2 conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Video-Chat Psychotherapy (VCP) consists of weekly psychotherapy appointments that last between 30-45 minutes.
These sessions are conducted using Agora, a secure, HIPAA-compliant video conferencing service that is seamlessly integrated into the Talkspace platform application.
Therapists will provide evidence-based treatments for depression and anxiety.
Message-Based Psychotherapy (MBP) with monthly Video-Chat Psychotherapy (VCP) allows patients unlimited texting with their therapist and once a month, 30-45 minute video chat with the same therapist.
Therapist and participants schedule their video chat appointment to occur at once a month interval during therapist office hours.
The content of these sessions, as well as the MBP portion of care, will be based on CBT, PST or IPT.
In Phase 1, this is referred to as "Switch Arm" (for participants assigned to VCP at baseline) or "Minimal Augmentation" (for participants assigned to MBP at baseline).
In Phase 2, this is referred to as the "Premium Plan".
|
|
Experimental: Phase 2: VCP (Level 1) to Ultimate Plan (MBP with weekly VCP; Level 2)
Phase 2: This arm includes participants in VCP (Level 1) who do not respond to treatment by week 5.
The Ultimate Plan intervention consists of MBP with weekly VCP (Level 2).
The Ultimate Plan allows patients unlimited MBP and weekly, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two Level 2 conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Video-Chat Psychotherapy (VCP) consists of weekly psychotherapy appointments that last between 30-45 minutes.
These sessions are conducted using Agora, a secure, HIPAA-compliant video conferencing service that is seamlessly integrated into the Talkspace platform application.
Therapists will provide evidence-based treatments for depression and anxiety.
Message-Based Psychotherapy (MBP) with weekly Video-Chat Psychotherapy (VCP) allows patients access to both unlimited MBP, but will be able to schedule weekly, 30-45 minute video chat with the same therapist.
Therapists will provide care based on CBT, PST or IPT.
In Phase 1, this is referred to as the "Augmentation Arm".
In Phase 2, this is referred to as the "Ultimate Plan."
|
|
Experimental: Phase 1: High Monetary Incentive (HMI) + VCP (Level 1 and Level 2)
Phase 1 participants who respond to VCP (Level 1) by 5 weeks of care will continue in this condition from weeks 6 to 12 (VCP; Level 2).
Participants in the High Monetary Incentive (HMI) arm received a total of $125 for completing 12 weeks of assessments.
|
Video-Chat Psychotherapy (VCP) consists of weekly psychotherapy appointments that last between 30-45 minutes.
These sessions are conducted using Agora, a secure, HIPAA-compliant video conferencing service that is seamlessly integrated into the Talkspace platform application.
Therapists will provide evidence-based treatments for depression and anxiety.
Participants in the traditional, high monetary incentive arm will receive a total of $125 for completing 12 weeks of assessments.
|
|
Experimental: Phase 1: High Monetary Incentive (HMI) + MBP (Level 1 and Level 2)
Phase 1 participants who respond to MBP (Level 1) by 5 weeks of care will continue in this condition from weeks 6 to 12 (MBP; Level 2).
Participants in the High Monetary Incentive (HMI) arm received a total of $125 for completing 12 weeks of assessments.
|
Message-Based Psychotherapy (MBP) allows patients to chat with an assigned licensed therapist as frequently as they wish.
After consumers complete an intake and select a therapist, the consumer can begin chatting with their therapist right away, and as often as they wish.
Therapists respond to text within 15 minutes to an hour during office hours, and within 14 hours outside of office hours.
Thus, MBP is not fully synchronous.
This enables therapists to deliver care to a larger number of patients than is possible under synchronous methods by disentangling the therapist's time from the patient's time to respond.
It also has the potential to improve quality as it gives the therapist time to think through the most effective response and intervention.
MBP will be based on CBT, PST or IPT intervention strategies.
Participants in the traditional, high monetary incentive arm will receive a total of $125 for completing 12 weeks of assessments.
|
|
Experimental: Phase 1: Low Monetary and Alternative Incentive (LMAI) + VCP (Level 1 and Level 2)
Phase 1 participants who respond to VCP (Level 1) by 5 weeks of care will continue in this condition from weeks 6 to 12 (VCP; Level 2).
Participants in the Low Monetary and Alternative Incentive (LMAI) arm received a total of $75 for completing 12 weeks of assessments, messages of encouragement for completing daily assessments, and weekly texts showing participants their clinical improvement and assessment completion rate.
|
Video-Chat Psychotherapy (VCP) consists of weekly psychotherapy appointments that last between 30-45 minutes.
These sessions are conducted using Agora, a secure, HIPAA-compliant video conferencing service that is seamlessly integrated into the Talkspace platform application.
Therapists will provide evidence-based treatments for depression and anxiety.
Participants in the Low Monetary and Alternative Incentive (LMAI) arm received a total of $75 for completing 12 weeks of assessments, messages of encouragement for completing daily assessments, and weekly texts showing participants their clinical improvement and assessment completion rate.
|
|
Experimental: Phase 1: Low Monetary and Alternative Incentive (LMAI) + MBP (Level 1 and Level 2)
Phase 1 participants who respond to MBP (Level 1) by 5 weeks of care will continue in this condition from weeks 6 to 12 (MBP; Level 2).
Participants in the Low Monetary and Alternative Incentive (LMAI) arm received a total of $75 for completing 12 weeks of assessments, messages of encouragement for completing daily assessments, and weekly texts showing participants their clinical improvement and assessment completion rate.
|
Message-Based Psychotherapy (MBP) allows patients to chat with an assigned licensed therapist as frequently as they wish.
After consumers complete an intake and select a therapist, the consumer can begin chatting with their therapist right away, and as often as they wish.
Therapists respond to text within 15 minutes to an hour during office hours, and within 14 hours outside of office hours.
Thus, MBP is not fully synchronous.
This enables therapists to deliver care to a larger number of patients than is possible under synchronous methods by disentangling the therapist's time from the patient's time to respond.
It also has the potential to improve quality as it gives the therapist time to think through the most effective response and intervention.
MBP will be based on CBT, PST or IPT intervention strategies.
Participants in the Low Monetary and Alternative Incentive (LMAI) arm received a total of $75 for completing 12 weeks of assessments, messages of encouragement for completing daily assessments, and weekly texts showing participants their clinical improvement and assessment completion rate.
|
|
Experimental: Phase 1: HMI + VCP (Level 1) to Augmentation Arm (MBP with weekly VCP; Level 2)
Phase 1: This arm includes participants in HMI + VCP (Level 1) who do not respond to treatment by week 5.
The Augmentation Arm consists of MBP with weekly VCP (Level 2).
Participants will have access to unlimited MBP and will be able to schedule weekly, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) with weekly Video-Chat Psychotherapy (VCP) allows patients access to both unlimited MBP, but will be able to schedule weekly, 30-45 minute video chat with the same therapist.
Therapists will provide care based on CBT, PST or IPT.
In Phase 1, this is referred to as the "Augmentation Arm".
In Phase 2, this is referred to as the "Ultimate Plan."
Participants in the traditional, high monetary incentive arm will receive a total of $125 for completing 12 weeks of assessments.
|
|
Experimental: Phase 1: HMI + VCP (Level 1) to Switch Arm (MBP with monthly VCP; Level 2)
Phase 1: This arm includes participants in HMI + VCP (Level 1) who do not respond to treatment by week 5.
The Switch Arm consists of MBP with monthly VCP (Level 2).
Patients have access to unlimited MBP and once a month, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) with monthly Video-Chat Psychotherapy (VCP) allows patients unlimited texting with their therapist and once a month, 30-45 minute video chat with the same therapist.
Therapist and participants schedule their video chat appointment to occur at once a month interval during therapist office hours.
The content of these sessions, as well as the MBP portion of care, will be based on CBT, PST or IPT.
In Phase 1, this is referred to as "Switch Arm" (for participants assigned to VCP at baseline) or "Minimal Augmentation" (for participants assigned to MBP at baseline).
In Phase 2, this is referred to as the "Premium Plan".
Participants in the traditional, high monetary incentive arm will receive a total of $125 for completing 12 weeks of assessments.
|
|
Experimental: Phase 1: HMI + MBP (Level 1) to Augmentation Arm (MBP with weekly VCP; Level 2)
Phase 1: This arm includes participants in HMI + MBP (Level 1) who do not respond to treatment by week 5.
The Augmentation Arm consists of MBP with weekly VCP (Level 2).
Participants will have access to unlimited MBP and will be able to schedule weekly, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) with weekly Video-Chat Psychotherapy (VCP) allows patients access to both unlimited MBP, but will be able to schedule weekly, 30-45 minute video chat with the same therapist.
Therapists will provide care based on CBT, PST or IPT.
In Phase 1, this is referred to as the "Augmentation Arm".
In Phase 2, this is referred to as the "Ultimate Plan."
Participants in the traditional, high monetary incentive arm will receive a total of $125 for completing 12 weeks of assessments.
|
|
Experimental: Phase 1: HMI + MBP (Level 1) to Minimal Augmentation (MBP with monthly VCP; Level 2)
Phase 1: This arm includes participants in HMI + MBP (Level 1) who do not respond to treatment by week 5.
The Minimal Augmentation arm consists of MBP with monthly VCP (Level 2).
Patients have access to unlimited MBP and once a month, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) with monthly Video-Chat Psychotherapy (VCP) allows patients unlimited texting with their therapist and once a month, 30-45 minute video chat with the same therapist.
Therapist and participants schedule their video chat appointment to occur at once a month interval during therapist office hours.
The content of these sessions, as well as the MBP portion of care, will be based on CBT, PST or IPT.
In Phase 1, this is referred to as "Switch Arm" (for participants assigned to VCP at baseline) or "Minimal Augmentation" (for participants assigned to MBP at baseline).
In Phase 2, this is referred to as the "Premium Plan".
Participants in the traditional, high monetary incentive arm will receive a total of $125 for completing 12 weeks of assessments.
|
|
Experimental: Phase 1: LMAI + VCP (Level 1) to Augmentation Arm (MBP with weekly VCP; Level 2)
Phase 1: This arm includes participants in LMAI + VCP (Level 1) who do not respond to treatment by week 5.
The Augmentation Arm consists of MBP with weekly VCP (Level 2).
Participants will have access to unlimited MBP and will be able to schedule weekly, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) with weekly Video-Chat Psychotherapy (VCP) allows patients access to both unlimited MBP, but will be able to schedule weekly, 30-45 minute video chat with the same therapist.
Therapists will provide care based on CBT, PST or IPT.
In Phase 1, this is referred to as the "Augmentation Arm".
In Phase 2, this is referred to as the "Ultimate Plan."
Participants in the Low Monetary and Alternative Incentive (LMAI) arm received a total of $75 for completing 12 weeks of assessments, messages of encouragement for completing daily assessments, and weekly texts showing participants their clinical improvement and assessment completion rate.
|
|
Experimental: Phase 1: LMAI + VCP (Level 1) to Switch Arm (MBP with monthly VCP; Level 2)
Phase 1: This arm includes participants in LMAI + VCP (Level 1) who do not respond to treatment by week 5.
The Switch Arm consists of MBP with monthly VCP (Level 2).
Patients have access to unlimited MBP and once a month, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) with monthly Video-Chat Psychotherapy (VCP) allows patients unlimited texting with their therapist and once a month, 30-45 minute video chat with the same therapist.
Therapist and participants schedule their video chat appointment to occur at once a month interval during therapist office hours.
The content of these sessions, as well as the MBP portion of care, will be based on CBT, PST or IPT.
In Phase 1, this is referred to as "Switch Arm" (for participants assigned to VCP at baseline) or "Minimal Augmentation" (for participants assigned to MBP at baseline).
In Phase 2, this is referred to as the "Premium Plan".
Participants in the Low Monetary and Alternative Incentive (LMAI) arm received a total of $75 for completing 12 weeks of assessments, messages of encouragement for completing daily assessments, and weekly texts showing participants their clinical improvement and assessment completion rate.
|
|
Experimental: Phase 1: LMAI + MBP (Level 1) to Augmentation Arm (MBP with weekly VCP; Level 2)
Phase 1: This arm includes participants in LMAI + MBP (Level 1) who do not respond to treatment by week 5.
The Augmentation Arm consists of MBP with weekly VCP (Level 2).
Participants will have access to unlimited MBP and will be able to schedule weekly, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) with weekly Video-Chat Psychotherapy (VCP) allows patients access to both unlimited MBP, but will be able to schedule weekly, 30-45 minute video chat with the same therapist.
Therapists will provide care based on CBT, PST or IPT.
In Phase 1, this is referred to as the "Augmentation Arm".
In Phase 2, this is referred to as the "Ultimate Plan."
Participants in the Low Monetary and Alternative Incentive (LMAI) arm received a total of $75 for completing 12 weeks of assessments, messages of encouragement for completing daily assessments, and weekly texts showing participants their clinical improvement and assessment completion rate.
|
|
Experimental: Phase 1: LMAI + MBP (Level 1) to Minimal Augmentation (MBP with monthly VCP; Level 2)
Phase 1: This arm includes participants in LMAI + MBP (Level 1) who do not respond to treatment by week 5.
The Minimal Augmentation arm consists of MBP with monthly VCP (Level 2).
Patients have access to unlimited MBP and once a month, 30-45 minute video chat with the same therapist.
This intervention will serve as one of two conditions for participants who do not respond to MBP or VCP alone by week 5.
|
Message-Based Psychotherapy (MBP) with monthly Video-Chat Psychotherapy (VCP) allows patients unlimited texting with their therapist and once a month, 30-45 minute video chat with the same therapist.
Therapist and participants schedule their video chat appointment to occur at once a month interval during therapist office hours.
The content of these sessions, as well as the MBP portion of care, will be based on CBT, PST or IPT.
In Phase 1, this is referred to as "Switch Arm" (for participants assigned to VCP at baseline) or "Minimal Augmentation" (for participants assigned to MBP at baseline).
In Phase 2, this is referred to as the "Premium Plan".
Participants in the Low Monetary and Alternative Incentive (LMAI) arm received a total of $75 for completing 12 weeks of assessments, messages of encouragement for completing daily assessments, and weekly texts showing participants their clinical improvement and assessment completion rate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Neuro-QOL - Ability to Participate in Social Roles and Activities
Time Frame: Change from Baseline Neuro-QOL at 6 weeks and 12 weeks after treatment starts
|
Neuro-Quality of Life v1.0 (Neuro-QOL).
The Neuro-QOL Ability to Participate in Social Roles and Activities short form item bank is an 8-item patient-rated measure of social functioning.
Items focus on difficulty participating in social, family, and work activities, and are rated on a 1 to 5 scale for a total score between 8 and 40.
Neuro-QOL scores were transformed into t-scores per the scoring manual; after transformation, total scores range from 24.1 to 60.2.
Transformed scores are reported.
Higher scores indicate less difficulty participating in social roles and activities.
The Neuro-QOL was not distributed in Phase 1.
|
Change from Baseline Neuro-QOL at 6 weeks and 12 weeks after treatment starts
|
|
Change in Patient Health Questionnaire (PHQ-9)
Time Frame: Change from Baseline PHQ-9 at 6 weeks and 12 weeks after treatment starts
|
The Patient Health Questionnaire-9 (PHQ-9) consists of 9 depression items and one disability item.
Each time is associated with a Diagnostic and Statistical Manual (DMS) symptom of depression, which the participant rates whether or not they have experienced the symptom over the last two weeks, with severity rating of 0-3.
It is one of the few measures that is brief (it takes less than one minute to give) and has been found to have excellent sensitivity to change over time.
Total scores range from 0-27, with higher scores indicating greater severity of depression.
|
Change from Baseline PHQ-9 at 6 weeks and 12 weeks after treatment starts
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Generalized Anxiety Disorder (GAD-7)
Time Frame: Change from Baseline GAD-7 at 6 weeks and 12 weeks after treatment starts
|
To assess for co-occurring anxiety, we will use the Generalized Anxiety Disorder-7 (GAD-7), a 7- item screener for generalized anxiety disorder (GAD).
Participants rate on a scale of 0-3 how much they have experienced symptoms of GAD in the last two weeks.
Total scores range from 0 to 21, with higher scores indicating greater severity of anxiety.
The scale is a valid screener for GAD.
|
Change from Baseline GAD-7 at 6 weeks and 12 weeks after treatment starts
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Expectations About Treatment: Treatment Rationale Scale (TRS)
Time Frame: Week 1
|
Expectations about treatment can influence outcomes.
To assess participant expectations, we will administer the Treatment Rationale Scale (TRS), a 4-item scale administered before the 2nd and last session.
The scale assesses patient expectations about the success of treatment.
Items are rated on a scale of 0 (not at all) to 10 (very).
Total scores range from 0 to 40, with higher scores indicating better outcomes.
1) How logical does your Talkspace treatment seem to you? 2) How confident are you that the treatment will be successful in eliminating your depression? 3) How confident would you be in recommending the treatment to a friend with depression? 4) If you were extremely depressed, would you be willing to undergo such treatment?
|
Week 1
|
|
Experience of Care and Health Outcomes Survey (ECHO)
Time Frame: 10 weeks after treatment starts
|
The Experience of Care and Health Outcomes Survey (ECHO) items assess whether consumers received timely treatment, enough information to support self-management, and were involved in treatment as much as they wanted.
ECHO is a reliable instrument with alpha = .85.
For quality of care, participants rated an adapted version of item 28 of the Consumer Assessment of Healthcare Providers and Systems (CAHPS) ECHO survey: "In the past 4 weeks, using any number from 0 to 10, where 0 is the worst mental health care possible and 10 is the best mental health care possible, what number would you use to rate the mental health care you received from Talkspace?"
Ratings range from 0 to 10. Higher scores indicate better quality of care received.
|
10 weeks after treatment starts
|
|
Working Alliance Inventory-Short Revised (WAI-SR)
Time Frame: 10 weeks after treatment starts
|
Participants rated therapeutic alliance using the Working Alliance Inventory-Short Revised (WAI-SR), a 12-item measure of therapeutic alliance (relationship between the consumer and therapist or coach) evaluating three domains: goals, tasks, and bond.
Items are rated on a scale from 1 to 5. Total scores range from 12-60, with higher scores indicating a more effective therapeutic relationship.
It is a reliable measure of alliance, with alpha = .92.
|
10 weeks after treatment starts
|
|
Tailoring Variable - Response to Treatment
Time Frame: 6 weeks after treatment starts
|
To determine whether patients move to Level 2 treatment (starting at week 6), we will used clinician administered Patient Health Questionnaire-9 (PHQ-9) between weeks 3 to 5 of treatment.
Response to treatment was defined as a PHQ-9 score less than 50% of the participant's baseline PHQ-9 score.
Response to treatment was also evaluated via therapist feedback.
Participants who responded to their Level 1 treatment assignment continued in that condition from weeks 6 to 12. Participants who did not respond to treatment were switched to either MBP with weekly VCP or to MBP with monthly VCP.
|
6 weeks after treatment starts
|
|
Treatment Use Variables: Number of Sessions Attended
Time Frame: 12 weeks after treatment starts
|
Phase 1: Number of distinct days of messaging plus number of live video sessions attended Phase 2: Number of sessions attended, defined as the number of sessions during which the client sent any messages or attended any video sessions, regardless of Level 1 condition (e.g., includes sessions during which participants in VCP only sent messages).
|
12 weeks after treatment starts
|
|
Treatment Use Variables: Number of Messages Sent
Time Frame: 12 weeks after treatment starts
|
Number of messages sent, regardless of condition (e.g., also includes number of messages sent by clients in VCP only).
|
12 weeks after treatment starts
|
|
Treatment Use Variables: Time Between Patient and Psychotherapist Contact
Time Frame: 12 weeks after treatment starts
|
Time between patient and psychotherapist contact, defined as the number of days from client's Level 1 randomization date to the date of first psychotherapist message or video call.
These data were available only for Phase 2.
|
12 weeks after treatment starts
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Arean P, Hull D, Pullmann MD, Heagerty PJ. Protocol for a sequential, multiple assignment, randomised trial to test the effectiveness of message-based psychotherapy for depression compared with telepsychotherapy. BMJ Open. 2021 Nov 2;11(11):e046958. doi: 10.1136/bmjopen-2020-046958.
- Pullmann MD, Rouvere J, Raue PJ, Griffith Fillipo IR, Mosser BA, Heagerty PJ, Fridling-Cook N, Padmanabhan A, Hull TD, Arean PA. Message-Based vs Video-Based Psychotherapy for Depression: A Randomized Clinical Trial. JAMA Netw Open. 2025 Oct 1;8(10):e2540065. doi: 10.1001/jamanetworkopen.2025.40065.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00010391
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Disorder
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
Sheba Medical CenterNot yet recruiting
-
ACADIA Pharmaceuticals Inc.RecruitingACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response (NORLIGHT)Depressive Disorder, Treatment-Resistant | Major Depressive Disorder (MDD)United States
-
Rotman Research Institute at BaycrestRecruitingMajor Depressive Disorder (MDD)Canada
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingDepression - Major Depressive Disorder | Depression Chronic | Treatment-Resistant Major Depressive Disorder | Depression DisorderSpain
-
Second Affiliated Hospital of Tsinghua UniversityNot yet recruiting
-
First People's Hospital of HangzhouNot yet recruitingMajor Depressive Disorder
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Recruiting
-
Shandong Provincial HospitalShandong UniversityRecruiting
-
Engrail Therapeutics INCCompletedMajor Depressive DisorderUnited Kingdom
Clinical Trials on Message-Based Psychotherapy (MBP)
-
TalkspaceUniversity of WashingtonCompletedDepression | AnxietyUnited States
-
The University of Hong KongThe Hong Kong Jockey Club Charities TrustActive, not recruitingDepressive Symptoms | Anxiety Symptoms | Mental DisorderHong Kong
-
TalkspaceNew York University; Columbia UniversityCompletedAnxiety Disorders | Depressive Symptoms
-
University of WashingtonThe Hope FoundationActive, not recruitingInsomnia | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8United States
-
Emory UniversityNational Cancer Institute (NCI)CompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Thomas Jefferson UniversityCompletedChronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Universidad Peruana Cayetano HerediaCompleted
-
University of PennsylvaniaCompletedColonoscopy | Adherence, Patient | Text MessagingUnited States
-
Caritas Institute of Higher EducationUnknownMessage-based Rehabilitation for Peripheral Artery Disease PatientsChina, Hong Kong